Gowardhan Krushi Ayurved Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 20-06-2024
- Paid Up Capital ₹ 0.10 M
as on 20-06-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.78 M
as on 20-06-2024
- Revenue 5.93%
(FY 2020)
- Profit 204.92%
(FY 2020)
- Ebitda 72.04%
(FY 2020)
- Net Worth 54.17%
(FY 2020)
- Total Assets -2.59%
(FY 2020)
About Gowardhan Krushi Ayurved
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.78 M.
Dayanand Arya and Baburav Ary serve as directors at the Company.
- CIN/LLPIN
U01403MH2015PTC269547
- Company No.
269547
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Parbhani, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Gowardhan Krushi Ayurved Private Limited offer?
Gowardhan Krushi Ayurved Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic,Herbal Drops & Concentrates, Pure Ghee, A2 Ghee, Marmalades, Bel Murabba, Fertilizers and Soil Additives, Organic Fertilizers and Manure, Cereals & Food Grains, Gud Jaggery.
Who are the key members and board of directors at Gowardhan Krushi Ayurved?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dayanand Arya  | Director | 24-Oct-2015 | Current |
| Baburav Ary | Director | 24-Oct-2015 | Current |
Financial Performance of Gowardhan Krushi Ayurved.
Gowardhan Krushi Ayurved Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 5.93% increase. The company also saw a substantial improvement in profitability, with a 204.92% increase in profit. The company's net worth Soared by an impressive increase of 54.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gowardhan Krushi Ayurved?
In 2017, Gowardhan Krushi Ayurved had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Feb 2021 | ₹0.78 M | Open |
How Many Employees Work at Gowardhan Krushi Ayurved?
Unlock and access historical data on people associated with Gowardhan Krushi Ayurved, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gowardhan Krushi Ayurved, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gowardhan Krushi Ayurved's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
